Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis
Bin Huang, Hui Wang, Shuo Liu, Hao Meng, Dan Luo, Yi Zhou, Ying Huang, Yong Nian 等 11 位
Peking University Shenzhen Bay Laboratory Shenzhen Medical Academy of Research and Translation Shandong University
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
S-palmitoylation is a reversible and widespread post-translational modification, but its role in the regulation of ferroptosis has been poorly understood. Here, we elucidate that GPX4, an essential regulator of ferroptosis, is reversibly palmitoylated on cysteine 66. The acyltransferase ZDHHC20 palmitoylates GPX4 and increases its protein stability. ZDHHC20 depletion or inhibition of protein palmitoylation by 2-BP sensitizes cancer cells to ferroptosis. Moreover, we identify APT2 as the depalmitoylase of GPX4. Genetic silencing or pharmacological inhibition of APT2 with ML349 increases GPX4 palmitoylation, thereby stabilizing the protein and conferring resistance to ferroptosis. Notably, disrupting GPX4 palmitoylation markedly potentiates ferroptosis in xenografted and orthotopically implanted tumor models, and inhibits tumor metastasis through blood vessels. In the chemically induced colorectal cancer model, knockout of APT2 significantly aggravates cancer progression. Furthermore, pharmacologically modulating GPX4 palmitoylation impacts liver ischemia–reperfusion injury. Overall, our findings uncover the intricate network regulating GPX4 palmitoylation, highlighting its pivotal role in modulating ferroptosis sensitivity. Ferroptosis is crucial in tumor growth, metastasis, and cancer therapy response. Here, the authors reveal that reversible palmitoylation of GPX4 by ZDHHC20 and APT2 regulates ferroptosis sensitivity, offering a potential target for therapeutic intervention.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Ferroptosis and cancer prognosis
Cancer, Lipids, and Metabolism · Iron Metabolism and Disorders